Author Correction: Integrated network analysis identifies hsa-miR-4756-3p as a regulator of FOXM1 in Triple Negative Breast Cancer

被引：0
|
作者：
Yuanliang Gu
Wenjuan Wang
Xuyao Wang
Hongyi Xie
Xiaojuan Ye
Peng Shu
机构：
[1] Beilun Branch Hospital of the First Affiliated Hospital of Medical School Zhejiang University,Department of Prevention and Health Care, the People’s Hospital of Beilun District
[2] Beilun Branch Hospital of the First Affiliated Hospital of Medical School Zhejiang University,Molecluar Laboratory, the People’s Hospital of Beilun District
[3] Beilun Branch Hospital of the First Affiliated Hospital of Medical School Zhejiang University,Department of Hematology and Oncology, the People’s Hospital of Beilun District
来源：
Scientific Reports | / 11卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Integrated network analysis identifies hsa-miR-4756-3p as a regulator of FOXM1 in Triple Negative Breast Cancer
    Gu, Yuanliang
    Wang, Wenjuan
    Wang, Xuyao
    Xie, Hongyi
    Ye, Xiaojuan
    Shu, Peng
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [2] Integrated network analysis identifies hsa-miR-4756-3p as a regulator of FOXM1 in Triple Negative Breast Cancer
    Yuanliang Gu
    Wenjuan Wang
    Xuyao Wang
    Hongyi Xie
    Xiaojuan Ye
    Peng Shu
    Scientific Reports, 9
  • [3] Integrated network analysis identifies hsa-miR-4756-3p as a regulator of FOXM1 in Triple Negative Breast Cancer (vol 9, 13830, 2019)
    Gu, Yuanliang
    Wang, Wenjuan
    Wang, Xuyao
    Xie, Hongyi
    Ye, Xiaojuan
    Shu, Peng
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [4] MicroRNA profiling identifies Forkhead box transcription factor M1 (FOXM1) regulated miR-186 and miR-200b alterations in triple negative breast cancer
    Hamurcu, Zuhal
    Sener, Elif Funda
    Taheri, Serpil
    Nalbantoglu, Ufuk
    Kokcu, Nesrin Delibasi
    Tahtasakal, Reyhan
    Cinar, Venhar
    Guler, Ahsen
    Ozkul, Yusuf
    Donmez-Altuntas, Hamiyet
    Ozpolat, Bulent
    CELLULAR SIGNALLING, 2021, 83
  • [5] miR-489 induces apoptosis and immunogenic cell death through targeting FOXM1 in triple negative breast cancer cells
    Gupta, Gourab
    Titus, Ryan
    Patel, Yogin
    Sarvanan, Shakthika
    Chen, Hexin
    CANCER RESEARCH, 2023, 83 (07)
  • [6] A microRNA signature identifies subtypes of triple-negative breast cancer and reveals MIR-342-3P as regulator of a lactate metabolic pathway
    Hidalgo-Miranda, A.
    Romero-Cordoba, S.
    Rodriguez-Cuevas, S.
    Rebollar-Vega, R.
    Tagliabue, E.
    Iorio, M.
    D'Ippolito, E.
    Baroni, S.
    HUMAN GENOMICS, 2016, 10
  • [7] mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK
    Liu, Peng
    Ye, Feng
    Xie, Xinhua
    Li, Xing
    Tang, Hailin
    Li, Shuaijie
    Huang, Xiaojia
    Song, Cailu
    Wei, Weidong
    Xie, Xiaoming
    ONCOTARGET, 2016, 7 (23) : 35188 - 35198
  • [8] Bioinformatics analysis identifies dysregulation of miR-548F-3p and its hub gene in triple-negative breast cancer
    Behroozi, Samira
    Salimi, Mahdieh
    Fard, Najaf Allahyari
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2025, 28 (04) : 434 - 443
  • [9] Dual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion
    Bayraktar, Recep
    Ivan, Cristina
    Bayraktar, Emine
    Kanlikilicer, Pinar
    Kabil, Nashwa N.
    Kahraman, Nermin
    Mokhlis, Hamada A.
    Karakas, Didem
    Rodriguez-Aguayo, Cristian
    Arslan, Ahmet
    Sheng, Jianting
    Wong, Stephen
    Lopez-Berestein, Gabriel
    Calin, George A.
    Ozpolat, Bulent
    CLINICAL CANCER RESEARCH, 2018, 24 (17) : 4225 - 4241
  • [10] A microRNA signature identifies subtypes of triple-negative breast cancer and reveals miR-342-3p as regulator of a lactate metabolic pathway through silencing monocarboxylate transporter 1
    Romero-Cordoba, Sandra L.
    Rodriguez-Cuevas, Sergio
    Rebollar-Vega, Rosa
    Bautista-Pina, Veronica
    Maffuz-Aziz, Antonio
    Tagliabue, Elda
    Lorio, Marilena
    D'Ippolito, Elvira
    Baroni, Sara
    Plantamura, Ilaria
    Hidalgo-Miranda, Alfredo
    CANCER RESEARCH, 2016, 76
12345